Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer

This study suggests that the DDC NPs possess noteworthy potential as prospects for the development of PCA clinical chemotherapy.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research